These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23621531)
1. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology. Baiu DC; Brazel CS; Bao Y; Otto M Curr Pharm Des; 2013; 19(37):6606-21. PubMed ID: 23621531 [TBL] [Abstract][Full Text] [Related]
2. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Peng XH; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM Int J Nanomedicine; 2008; 3(3):311-21. PubMed ID: 18990940 [TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Zhu L; Zhou Z; Mao H; Yang L Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448 [TBL] [Abstract][Full Text] [Related]
4. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Kievit FM; Zhang M Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865 [TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics? Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009 [TBL] [Abstract][Full Text] [Related]
7. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815 [TBL] [Abstract][Full Text] [Related]
8. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy. Hu Y; Mignani S; Majoral JP; Shen M; Shi X Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542 [TBL] [Abstract][Full Text] [Related]
9. Theranostic Iron Oxide/Gold Ion Nanoprobes for MR Imaging and Noninvasive RF Hyperthermia. Fazal S; Paul-Prasanth B; Nair SV; Menon D ACS Appl Mater Interfaces; 2017 Aug; 9(34):28260-28272. PubMed ID: 28789518 [TBL] [Abstract][Full Text] [Related]
10. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer. Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153 [TBL] [Abstract][Full Text] [Related]
11. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies. Soetaert F; Korangath P; Serantes D; Fiering S; Ivkov R Adv Drug Deliv Rev; 2020; 163-164():65-83. PubMed ID: 32603814 [TBL] [Abstract][Full Text] [Related]
12. Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery. Wen Y; Xu M; Liu X; Jin X; Kang J; Xu D; Sang H; Gao P; Chen X; Zhao L Colloids Surf B Biointerfaces; 2019 Jan; 173():842-850. PubMed ID: 30551300 [TBL] [Abstract][Full Text] [Related]
13. Applications of nanoparticles for diagnosis and therapy of cancer. Baetke SC; Lammers T; Kiessling F Br J Radiol; 2015 Oct; 88(1054):20150207. PubMed ID: 25969868 [TBL] [Abstract][Full Text] [Related]
14. A Review of Clinical Translation of Inorganic Nanoparticles. Anselmo AC; Mitragotri S AAPS J; 2015 Sep; 17(5):1041-54. PubMed ID: 25956384 [TBL] [Abstract][Full Text] [Related]
15. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046 [TBL] [Abstract][Full Text] [Related]
17. Challenges to effective cancer nanotheranostics. Melancon MP; Stafford RJ; Li C J Control Release; 2012 Dec; 164(2):177-82. PubMed ID: 22906841 [TBL] [Abstract][Full Text] [Related]
18. Facile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy. Huang G; Zhu X; Li H; Wang L; Chi X; Chen J; Wang X; Chen Z; Gao J Nanoscale; 2015 Feb; 7(6):2667-75. PubMed ID: 25581879 [TBL] [Abstract][Full Text] [Related]
19. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging. Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458 [TBL] [Abstract][Full Text] [Related]
20. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects. Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]